Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study of Weekly Oral Ecnoglutide (VRB-101) in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

ClinicalTrials.gov ID: NCT07281937

Public ClinicalTrials.gov record NCT07281937. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 2:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study of Weekly Oral Ecnoglutide (VRB-101) in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The aim of this study is to evaluate the efficacy of VRB-101 for body weight reduction compared to placebo in participants who have obesity or overweight with weight-related comorbidities.

Study identification

NCT ID
NCT07281937
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Verdiva Bio Dev Limited
Industry
Enrollment
206 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 25, 2025 (Actual)
Primary completion
Jul 23, 2026 (Actual)
Completion
Jul 23, 2026 (Actual)
Last update posted
Aug 17, 2026

2025 – 2026

United States locations

U.S. sites
22
U.S. states
15
U.S. cities
21
Facility City State ZIP Site status
Clinical Study Site 103 Anniston Alabama 36207 —
Clinical Study Site 109 Cullman Alabama 35055 —
Clinical Study Site 110 Phoenix Arizona 85028 —
Clinical Study Site 113 Little Rock Arkansas 72205 —
Clinical Study Site 111 Anaheim California 92801 —
Clinical Study Site 107 Montclair California 91763 —
Clinical Study Site 118 Tarzana California 91356 —
Clinical Study Site 119 Decatur Georgia 30030 —
Clinical Study Site 116 West Des Moines Iowa 50266 —
Clinical Study Site 106 Wichita Kansas 67207 —
Clinical Study Site 122 Southfield Michigan 48076 —
Clinical Study Site 121 Omaha Nebraska 68134 —
Clinical Study Site 117 Binghamton New York 13905 —
Clinical Study Site 101 Rochester New York 14609 —
Clinical Study Site 120 Charlotte North Carolina 28210 —
Clinical Study Site 108 Monroe North Carolina 28112 —
Clinical Study Site 105 Norman Oklahoma 73069 —
Clinical Study Site 114 Duncansville Pennsylvania 16635 —
Clinical Study Site 115 Knoxville Tennessee 37909 —
Clinical Study Site 112 Dallas Texas 75251 —
Clinical Study Site 102 San Antonio Texas 78229 —
Clinical Study Site 104 San Antonio Texas 78240 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07281937, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 17, 2026 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07281937 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →